Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid Cancer
Objective In this study, we aimed to perform a comprehensive analysis to assess the prognostic value of neutrophil-to-lymphocyte ratio (NLR) levels in patients diagnosed with thyroid cancer. Methods We systematically searched multiple databases, including PubMed, the Cochrane Library, EMBASE, and Go...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748241309048 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846116269867139072 |
|---|---|
| author | Qiangang Gao MMS Mingming Quan MMS Lilong Zhang PhD Yanyun Ran MMS Jijun Zhong MMS Bin Wang MMS |
| author_facet | Qiangang Gao MMS Mingming Quan MMS Lilong Zhang PhD Yanyun Ran MMS Jijun Zhong MMS Bin Wang MMS |
| author_sort | Qiangang Gao MMS |
| collection | DOAJ |
| description | Objective In this study, we aimed to perform a comprehensive analysis to assess the prognostic value of neutrophil-to-lymphocyte ratio (NLR) levels in patients diagnosed with thyroid cancer. Methods We systematically searched multiple databases, including PubMed, the Cochrane Library, EMBASE, and Google Scholar, up until March 30, 2023, to identify relevant articles. The clinical outcomes evaluated in this study included overall survival (OS), progression-free survival (PFS), disease-free survival (DFS), and cause-specific survival (CSS). Results This analysis includes 21 articles with 5187 patients in total. The pooled results revealed that patients with high NLR levels had significantly poorer OS (HR: 2.578, 95% CI: 2.050-3.242, P < 0.001), PFS (HR: 2.143, 95% CI: 1.616-2.843, P < 0.001), DFS (HR: 1.377, 95% CI: 1.045-1.816, P = 0.023), and CSS (HR: 2.842, 95% CI: 1.334-6.053, P = 0.007). The subgroup analyses were performed based on different study regions, treatment modalities, cancer types, and NLR cut-off values, and the above conclusion remained consistent in the majority of subgroup analyses. The stability and reliability of the aforementioned results were supported by the sensitivity analysis and publication bias test. Conclusion The baseline NLR levels were useful predictors of outcomes in patients with thyroid cancer. |
| format | Article |
| id | doaj-art-c1e0b4631dc84f3fb0272241fbdd68f1 |
| institution | Kabale University |
| issn | 1526-2359 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Cancer Control |
| spelling | doaj-art-c1e0b4631dc84f3fb0272241fbdd68f12024-12-19T09:03:23ZengSAGE PublishingCancer Control1526-23592024-12-013110.1177/10732748241309048Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid CancerQiangang Gao MMSMingming Quan MMSLilong Zhang PhDYanyun Ran MMSJijun Zhong MMSBin Wang MMSObjective In this study, we aimed to perform a comprehensive analysis to assess the prognostic value of neutrophil-to-lymphocyte ratio (NLR) levels in patients diagnosed with thyroid cancer. Methods We systematically searched multiple databases, including PubMed, the Cochrane Library, EMBASE, and Google Scholar, up until March 30, 2023, to identify relevant articles. The clinical outcomes evaluated in this study included overall survival (OS), progression-free survival (PFS), disease-free survival (DFS), and cause-specific survival (CSS). Results This analysis includes 21 articles with 5187 patients in total. The pooled results revealed that patients with high NLR levels had significantly poorer OS (HR: 2.578, 95% CI: 2.050-3.242, P < 0.001), PFS (HR: 2.143, 95% CI: 1.616-2.843, P < 0.001), DFS (HR: 1.377, 95% CI: 1.045-1.816, P = 0.023), and CSS (HR: 2.842, 95% CI: 1.334-6.053, P = 0.007). The subgroup analyses were performed based on different study regions, treatment modalities, cancer types, and NLR cut-off values, and the above conclusion remained consistent in the majority of subgroup analyses. The stability and reliability of the aforementioned results were supported by the sensitivity analysis and publication bias test. Conclusion The baseline NLR levels were useful predictors of outcomes in patients with thyroid cancer.https://doi.org/10.1177/10732748241309048 |
| spellingShingle | Qiangang Gao MMS Mingming Quan MMS Lilong Zhang PhD Yanyun Ran MMS Jijun Zhong MMS Bin Wang MMS Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid Cancer Cancer Control |
| title | Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid Cancer |
| title_full | Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid Cancer |
| title_fullStr | Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid Cancer |
| title_full_unstemmed | Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid Cancer |
| title_short | Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid Cancer |
| title_sort | neutrophil to lymphocyte ratio as a prognostic indicator in thyroid cancer |
| url | https://doi.org/10.1177/10732748241309048 |
| work_keys_str_mv | AT qianganggaomms neutrophiltolymphocyteratioasaprognosticindicatorinthyroidcancer AT mingmingquanmms neutrophiltolymphocyteratioasaprognosticindicatorinthyroidcancer AT lilongzhangphd neutrophiltolymphocyteratioasaprognosticindicatorinthyroidcancer AT yanyunranmms neutrophiltolymphocyteratioasaprognosticindicatorinthyroidcancer AT jijunzhongmms neutrophiltolymphocyteratioasaprognosticindicatorinthyroidcancer AT binwangmms neutrophiltolymphocyteratioasaprognosticindicatorinthyroidcancer |